Platelet-derived growth factor receptor alpha (PDGFRα) targeting and relevant biomarkers in ovarian carcinoma

Gynecologic Oncology

Volumn 132, Issue 1, 2014, Pages 166-175

  Matsuo, Koji ^a,b,c   Nishimura, Masato ^a   Komurov, Kakajan ^a   Shahzad, Mian M K ^a   Ali Fehmi, Rouba ^d   Roh, Ju Won ^a   Lu, Chunhua ^a   Cody, Dianna D ^a   Ram, Prahlad T ^a   Loizos, Nick ^e   Coleman, Robert L ^a   Sood, Anil K ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ELI LILLY AND COMPANY   (United States)

Author keywords

EGFR; IMC 3G3; MAPK; Ovarian cancer; Platelet derived growth factor receptor alpha

Indexed keywords

DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; OLARATUMAB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN KINASE B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER SURVIVAL; CELL VIABILITY; CHEMOSENSITIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; IC 50; IN VITRO STUDY; MONOTHERAPY; MOUSE; NONHUMAN; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN TARGETING; RECURRENCE RISK; TISSUE MICROARRAY; TREATMENT RESPONSE; TUMOR VASCULARIZATION;

EGFR; IMC-3G3; MAPK; OVARIAN CANCER; PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; BIOLOGICAL MARKERS; FEMALE; HUMANS; MICE; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; SIGNAL TRANSDUCTION; TAXOIDS;

EID: 84892794764     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.10.027     Document Type: Article

References (23)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 1 2013 11 30
2. K. Matsuo, Y.G. Lin, L.D. Roman, and A.K. Sood Overcoming platinum resistance in ovarian carcinoma Expert Opin Investig Drugs 19 11 2010 1339 1354 [PMCID: 2962713]
3. K. Matsuo, V.K. Bond, M.L. Eno, D.D. Im, and N.B. Rosenshein Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer Int J Cancer 125 11 2009 2721 2727
4. J. Andrae, R. Gallini, and C. Betsholtz Role of platelet-derived growth factors in physiology and medicine Genes Dev 22 10 2008 1276 1312 [PMCID: 2732412]
5. A.M. Oseini, and L.R. Roberts PDGFRalpha: a new therapeutic target in the treatment of hepatocellular carcinoma? Expert Opin Ther Targets 13 4 2009 443 454
6. D. Matei, R.E. Emerson, Y.C. Lai, L.A. Baldridge, J. Rao, and C. Yiannoutsos et al. Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer Oncogene 25 14 2006 2060 2069
7. S.P. Wilczynski, Y.Y. Chen, W. Chen, S.B. Howell, J.E. Shively, and D.S. Alberts Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers Hum Pathol 36 3 2005 242 249
8. H. Lassus, H. Sihto, A. Leminen, S. Nordling, H. Joensuu, and N.N. Nupponen et al. Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma Br J Cancer 91 12 2004 2048 2055 [PMCID: 2409787]
9. G.D. Shah, N. Loizos, H. Youssoufian, J.D. Schwartz, and E.K. Rowinsky Rationale for the development of IMC-3G3, a fully human immunoglobulin G subclass 1 monoclonal antibody targeting the platelet-derived growth factor receptor alpha Cancer 116 4 Suppl. 2010 1018 1026
10. J.W. Lee, H.D. Han, M.M. Shahzad, S.W. Kim, L.S. Mangala, and A.M. Nick et al. EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma J Natl Cancer Inst 101 17 2009 1193 1205 [PMCID: 2736292]
11. J. Halder, A.A. Kamat, C.N. Landen Jr., L.Y. Han, S.K. Lutgendorf, and Y.G. Lin et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy Clin Cancer Res 12 16 2006 4916 4924
12. L.S. Mangala, V. Zuzel, R. Schmandt, E.S. Leshane, J.B. Halder, and G.N. Armaiz-Pena et al. Therapeutic targeting of ATP7B in ovarian carcinoma Clin Cancer Res 15 11 2009 3770 3780 [PMCID: 2752981]
13. M.M. Shahzad, C. Lu, J.W. Lee, R.L. Stone, R. Mitra, and L.S. Mangala et al. Dual targeting of EphA2 and FAK in ovarian carcinoma Cancer Biol Ther 8 11 2009 1027 1034 [PMCID: 2748749]
14. http://inside.mdanderson.org/departments/ccsg/functional-proteomics-rppa- core/reversephase-services.html
15. http://bioinformatics.mdanderson.org/OOMPA
16. N. Loizos, Y. Xu, J. Huber, M. Liu, D. Lu, and B. Finnerty et al. Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target Mol Cancer Ther 4 3 2005 369 379
17. C. Lu, T. Bonome, Y. Li, A.A. Kamat, L.Y. Han, and R. Schmandt et al. Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma Cancer Res 67 4 2007 1757 1768
18. K. Komurov, D. Padron, T. Cheng, M. Roth, K.P. Rosenblatt, and M.A. White Comprehensive mapping of the human kinome to epidermal growth factor receptor signaling J Biol Chem 285 27 2010 21134 21142 [PMCID: 2898331]
19. Komurov K, White MA, Ram PT. Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data. PLoS Comput Biol 6(8). PMCID: 2924243.
20. http://research.cchmc.org/netwalker
21. S.R. Kumar, J. Singh, G. Xia, V. Krasnoperov, L. Hassanieh, and E.J. Ley et al. Receptor tyrosine kinase EphB4 is a survival factor in breast cancer Am J Pathol 169 1 2006 279 293 [PMCID: 1698769]
22. N. Prenzel, E. Zwick, M. Leserer, and A. Ullrich Tyrosine kinase signalling in breast cancer. Epidermal growth factor receptor: convergence point for signal integration and diversification Breast Cancer Res 2 3 2000 184 190 [PMCID: 138773]
23. P. Liu, and R.G. Anderson Spatial organization of EGF receptor transmodulation by PDGF Biochem Biophys Res Commun 261 3 1999 695 700